WO2019177654A1 - Système et procédé d'utilisation d'énergie pour traiter un tissu biologique - Google Patents
Système et procédé d'utilisation d'énergie pour traiter un tissu biologique Download PDFInfo
- Publication number
- WO2019177654A1 WO2019177654A1 PCT/US2018/042903 US2018042903W WO2019177654A1 WO 2019177654 A1 WO2019177654 A1 WO 2019177654A1 US 2018042903 W US2018042903 W US 2018042903W WO 2019177654 A1 WO2019177654 A1 WO 2019177654A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- para
- energy
- treatment
- target tissue
- tissue
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 58
- 230000008569 process Effects 0.000 title claims abstract description 30
- 238000011282 treatment Methods 0.000 claims abstract description 240
- 230000006378 damage Effects 0.000 claims abstract description 33
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 26
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 228
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 228
- 238000002604 ultrasonography Methods 0.000 claims description 74
- 230000004913 activation Effects 0.000 claims description 59
- 230000000451 tissue damage Effects 0.000 claims description 10
- 231100000827 tissue damage Toxicity 0.000 claims description 10
- 230000004936 stimulating effect Effects 0.000 claims description 7
- 230000003213 activating effect Effects 0.000 claims description 4
- 238000011221 initial treatment Methods 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 314
- 238000001994 activation Methods 0.000 description 56
- 210000004027 cell Anatomy 0.000 description 53
- 230000005855 radiation Effects 0.000 description 42
- 102000004169 proteins and genes Human genes 0.000 description 35
- 108090000623 proteins and genes Proteins 0.000 description 35
- 238000010521 absorption reaction Methods 0.000 description 32
- 230000002207 retinal effect Effects 0.000 description 32
- 230000000694 effects Effects 0.000 description 28
- 230000003287 optical effect Effects 0.000 description 27
- 238000010438 heat treatment Methods 0.000 description 22
- 230000008901 benefit Effects 0.000 description 19
- 238000004519 manufacturing process Methods 0.000 description 19
- 230000005670 electromagnetic radiation Effects 0.000 description 17
- 230000006870 function Effects 0.000 description 17
- 230000006399 behavior Effects 0.000 description 16
- 230000007246 mechanism Effects 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 230000005451 protein repair Effects 0.000 description 15
- 241000894007 species Species 0.000 description 15
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 14
- 230000014509 gene expression Effects 0.000 description 14
- 230000001413 cellular effect Effects 0.000 description 13
- 230000006698 induction Effects 0.000 description 13
- 210000001525 retina Anatomy 0.000 description 13
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 13
- 230000001965 increasing effect Effects 0.000 description 12
- 230000008439 repair process Effects 0.000 description 12
- 238000009792 diffusion process Methods 0.000 description 11
- 210000000624 ear auricle Anatomy 0.000 description 11
- 230000007423 decrease Effects 0.000 description 10
- 230000006872 improvement Effects 0.000 description 10
- 108020004999 messenger RNA Proteins 0.000 description 10
- 230000035939 shock Effects 0.000 description 10
- 239000000835 fiber Substances 0.000 description 9
- 230000035515 penetration Effects 0.000 description 9
- 238000000926 separation method Methods 0.000 description 9
- 238000003491 array Methods 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000002775 capsule Substances 0.000 description 8
- 230000007774 longterm Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000013307 optical fiber Substances 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 6
- 230000027455 binding Effects 0.000 description 6
- 210000000805 cytoplasm Anatomy 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 5
- 230000001086 cytosolic effect Effects 0.000 description 5
- 230000001066 destructive effect Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000005286 illumination Methods 0.000 description 5
- 239000006187 pill Substances 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 101100507655 Canis lupus familiaris HSPA1 gene Proteins 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 4
- 108090000695 Cytokines Proteins 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 206010012688 Diabetic retinal oedema Diseases 0.000 description 4
- 206010012689 Diabetic retinopathy Diseases 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 230000001934 delay Effects 0.000 description 4
- 201000011190 diabetic macular edema Diseases 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000005684 electric field Effects 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 231100000518 lethal Toxicity 0.000 description 4
- 230000001665 lethal effect Effects 0.000 description 4
- 210000003928 nasal cavity Anatomy 0.000 description 4
- 238000013021 overheating Methods 0.000 description 4
- 210000000664 rectum Anatomy 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 101100506686 Arabidopsis thaliana HSFA1B gene Proteins 0.000 description 3
- 101100421857 Caenorhabditis elegans sod-2 gene Proteins 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- 101150017616 Hsf3 gene Proteins 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 101100071480 Oryza sativa subsp. japonica HSFA1 gene Proteins 0.000 description 3
- 206010064930 age-related macular degeneration Diseases 0.000 description 3
- 230000003466 anti-cipated effect Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000005779 cell damage Effects 0.000 description 3
- 230000003915 cell function Effects 0.000 description 3
- 208000037887 cell injury Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 208000002780 macular degeneration Diseases 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000000649 photocoagulation Effects 0.000 description 3
- 238000001126 phototherapy Methods 0.000 description 3
- 201000007914 proliferative diabetic retinopathy Diseases 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 239000000790 retinal pigment Substances 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000003437 trachea Anatomy 0.000 description 3
- 239000013638 trimer Substances 0.000 description 3
- 230000004304 visual acuity Effects 0.000 description 3
- 0 CC(C)CCCC(*P)N Chemical compound CC(C)CCCC(*P)N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010050031 Muscle strain Diseases 0.000 description 2
- 208000017442 Retinal disease Diseases 0.000 description 2
- 206010038923 Retinopathy Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000001363 autoimmune Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 230000004637 cellular stress Effects 0.000 description 2
- 230000001427 coherent effect Effects 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 238000002052 colonoscopy Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 208000014951 hematologic disease Diseases 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 238000013532 laser treatment Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000003818 metabolic dysfunction Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 210000001989 nasopharynx Anatomy 0.000 description 2
- 231100001160 nonlethal Toxicity 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000000246 remedial effect Effects 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 210000001533 respiratory mucosa Anatomy 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 230000004393 visual impairment Effects 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010071155 Autoimmune arthritis Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000033379 Chorioretinopathy Diseases 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 102000018932 HSP70 Heat-Shock Proteins Human genes 0.000 description 1
- 108010027992 HSP70 Heat-Shock Proteins Proteins 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 208000001344 Macular Edema Diseases 0.000 description 1
- 206010025415 Macular oedema Diseases 0.000 description 1
- 206010064912 Malignant transformation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 206010057430 Retinal injury Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- 102000004389 Ribonucleoproteins Human genes 0.000 description 1
- 108010081734 Ribonucleoproteins Proteins 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000010455 autoregulation Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000007960 cellular response to stress Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 201000008615 cone dystrophy Diseases 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000011325 dry age related macular degeneration Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000002839 fiber optic waveguide Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000010230 macular retinal edema Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000036212 malign transformation Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- SYHGEUNFJIGTRX-UHFFFAOYSA-N methylenedioxypyrovalerone Chemical compound C=1C=C2OCOC2=CC=1C(=O)C(CCC)N1CCCC1 SYHGEUNFJIGTRX-UHFFFAOYSA-N 0.000 description 1
- 238000013533 micropulse laser treatment Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000886 photobiology Effects 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000006432 protein unfolding Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000004243 retinal function Effects 0.000 description 1
- 208000004644 retinal vein occlusion Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000007725 thermal activation Methods 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
- A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/00863—Retina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00897—Scanning mechanisms or algorithms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/063—Radiation therapy using light comprising light transmitting means, e.g. optical fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0078—Ultrasound therapy with multiple treatment transducers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/02—Radiation therapy using microwaves
- A61N5/022—Apparatus adapted for a specific treatment
- A61N5/025—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Ophthalmology & Optometry (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Laser Surgery Devices (AREA)
Abstract
L'invention concerne un procédé de traitement thermique de tissu biologique comprenant l'utilisation d'une pluralité d'émetteurs d'énergie formés en un réseau. De l'énergie de traitement est générée à partir de la pluralité d'émetteurs et appliquée au tissu cible. L'énergie de traitement possède des paramètres d'énergie et d'application sélectionnés de façon à élever suffisamment la température de tissu cible pour créer un effet thérapeutique tout en maintenant une température moyenne du tissu cible pendant plusieurs minutes à ou sous une température prédéterminée de façon à ne pas détruire ou endommager de façon permanente le tissu cible.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA3091103A CA3091103A1 (fr) | 2018-03-12 | 2018-07-19 | Systeme et procede d'utilisation d'energie pour traiter un tissu biologique |
| EP18910135.5A EP3745972A4 (fr) | 2018-03-12 | 2018-07-19 | Système et procédé d'utilisation d'énergie pour traiter un tissu biologique |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/918,487 | 2018-03-12 | ||
| US15/918,487 US10874873B2 (en) | 2012-05-25 | 2018-03-12 | Process utilizing pulsed energy to heat treat biological tissue |
| US16/039,779 US11077318B2 (en) | 2012-05-25 | 2018-07-19 | System and process of utilizing energy for treating biological tissue |
| US16/039,779 | 2018-07-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2019177654A1 true WO2019177654A1 (fr) | 2019-09-19 |
Family
ID=67908015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2018/042903 WO2019177654A1 (fr) | 2018-03-12 | 2018-07-19 | Système et procédé d'utilisation d'énergie pour traiter un tissu biologique |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA3091103A1 (fr) |
| WO (1) | WO2019177654A1 (fr) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8414509B2 (en) * | 2002-01-23 | 2013-04-09 | The Regents Of The University Of California | Implantable thermal treatment method and apparatus |
| US9192780B2 (en) * | 1998-11-30 | 2015-11-24 | L'oreal | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders |
| US20160296374A1 (en) * | 2012-05-25 | 2016-10-13 | Ojai Retinal Technology, Llc | System and process for retina phototherapy |
| US20160338757A1 (en) | 2012-05-25 | 2016-11-24 | Ojai Retinal Technology, Llc | Method for heat treating biological tissues using pulsed energy sources |
| US20160361572A1 (en) * | 2011-07-10 | 2016-12-15 | Guided Therapy Systems, Llc | Systems and Methods for Accelerating Healing of Implanted Material and/or Native Tissue |
| US20170031983A1 (en) | 2015-07-30 | 2017-02-02 | Sap Se | Template based generation of cross views |
| US9561357B2 (en) * | 2013-03-15 | 2017-02-07 | Sonovia Holdings Llc | Light and ultrasonic transducer device for skin therapy |
-
2018
- 2018-07-19 WO PCT/US2018/042903 patent/WO2019177654A1/fr unknown
- 2018-07-19 CA CA3091103A patent/CA3091103A1/fr active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9192780B2 (en) * | 1998-11-30 | 2015-11-24 | L'oreal | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders |
| US8414509B2 (en) * | 2002-01-23 | 2013-04-09 | The Regents Of The University Of California | Implantable thermal treatment method and apparatus |
| US20160361572A1 (en) * | 2011-07-10 | 2016-12-15 | Guided Therapy Systems, Llc | Systems and Methods for Accelerating Healing of Implanted Material and/or Native Tissue |
| US20160296374A1 (en) * | 2012-05-25 | 2016-10-13 | Ojai Retinal Technology, Llc | System and process for retina phototherapy |
| US20160338757A1 (en) | 2012-05-25 | 2016-11-24 | Ojai Retinal Technology, Llc | Method for heat treating biological tissues using pulsed energy sources |
| US9561357B2 (en) * | 2013-03-15 | 2017-02-07 | Sonovia Holdings Llc | Light and ultrasonic transducer device for skin therapy |
| US20170031983A1 (en) | 2015-07-30 | 2017-02-02 | Sap Se | Template based generation of cross views |
Non-Patent Citations (4)
| Title |
|---|
| "Emerging Imaging Technologies", 2012, CRC PRESS |
| "The CRC Handbook of Thermal Engineering", 2000, SPRINGER SCIENCE AND BUSINESS MEDIA |
| M. RYBINSKIZ.SZYMANSKAS. LASOTAA. GAMBIN: "Modeling the efficacy of hyperthermia treatment", JOURNAL OF THE ROYAL SOCIETY INTERFACE, vol. 10, no. 88, 2013, pages 20130527 |
| See also references of EP3745972A4 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3091103A1 (fr) | 2019-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10531908B2 (en) | Method for heat treating biological tissues using pulsed energy sources | |
| US9427602B2 (en) | Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair | |
| US20170203132A1 (en) | System and process utilizing pulsed energy to treat biological tissue | |
| AU2020213374B2 (en) | Method for heat treating biological tissues using pulsed energy sources | |
| JP6778772B2 (ja) | 標的とされた熱ショックタンパク質を刺激する及びタンパク質修復を促進するためのパルス状の電磁療法および超音波治療法 | |
| US20210346713A1 (en) | System and process of utilizing light energy for treating biological tissue | |
| US11033749B2 (en) | Process utilizing pulsed energy to heat treat biological tissue | |
| AU2018236202B2 (en) | Process utilizing pulsed energy to heat treat biological tissue | |
| AU2017308587A1 (en) | Process for providing protective therapy for biological tissues or fluids | |
| US20230103544A1 (en) | System and process for utilizing energy for neuroregeneration | |
| WO2019177654A1 (fr) | Système et procédé d'utilisation d'énergie pour traiter un tissu biologique | |
| EP3745972A1 (fr) | Système et procédé d'utilisation d'énergie pour traiter un tissu biologique | |
| WO2018169560A1 (fr) | Système et procédé utilisant une énergie pulsée pour traiter un tissu biologique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18910135 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 3091103 Country of ref document: CA |
|
| ENP | Entry into the national phase |
Ref document number: 2018910135 Country of ref document: EP Effective date: 20200831 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |